Zhou Yan,Fan Jianfeng,Cheng Ming.Research therapeutic advances of atropine for hypertrophic pyloric stenosis[J].Journal of Clinical Pediatric Surgery,,():485-488.[doi:10.3760/cma.j.cn101785-202301026-017]
Research therapeutic advances of atropine for hypertrophic pyloric stenosis
- Keywords:
- Hypertrophic Pyloric Stenosis; Atropine
- Abstract:
- Hypertrophic pyloric stenosis (HPS) is a common condition caused by gastric outlet obstruction.Its pathogenesis has remained elusive.Hypertrophy of pylorus may be secondary to persistent spasm of pyloric muscle.As a M-choline receptor blocker,atropine treats HPS effectively through relieving gastrointestinal smooth muscle spasm.With recent popularization of a new regimen of atropine,the conservative treatment of HPS has attracted greater attention.This review summarized the latest researches in atropine dosing for HPS to provide rationales for its clinical applications and researches.
References:
[1] Singh UK,Kumar R.Congenital hypertrophic pyloric stenosis[J].Indian J Pediatr,2002,69(8):713-715.DOI:10.1007/BF02722710.
[2] Imura K,Kawahara H,Yagi M,et al.Pyloric motor abnormality in patients with infantile hypertrophic pyloric stenosis[J].Pediatr Surg Int,1998,14(3):178-181.DOI:10.1007/s003830050480.
[3] Kawahara H,Imura K,Yagi M,et al.Motor abnormality in the gastroduodenal junction in patients with infantile hypertrophic pyloric stenosis[J].J Pediatr Surg,2001,36(11):1641-1645.DOI:10.1053/jpsu.2001.27939.
[4] Sretenovi? A,Smoljani? Z,Kora? G,et al.Conservative treatment of hypertrophic pyloric stenosis in children[J].Srp Arh Celok Lek,2004,132(Suppl 1):93-96.DOI:10.2298/sarh04s1093s.
[5] Boybeyi O,Soyer T,Atasoy P,et al.Investigation of the effects of enteral hormones on the pyloric muscle in newborn rats[J].J Pediatr Surg,2015,50(3):408-412.DOI:10.1016/j.jpedsurg.2014.05.036.
[6] Boybeyi-Turer O,Celik HT,Arslan UE,et al.Environmental exposure in the etiology of infantile hypertrophic pyloric stenosis:a systematic review and meta-analysis[J].Pediatr Surg Int,2022,38(7):951-961.DOI:10.1007/s00383-022-05128-9.
[7] Paran M,Freud E,Samuk I,et al.Does maternal omega 3 supplementation protect against infantile hypertrophic pyloric stenosis?[J].J Pediatr Gastroenterol Nutr,2020,70(5):652-656.DOI:10.1097/MPG.0000000000002648.
[8] Abdellatif M,Ghozy S,Kamel MG,et al.Association between exposure to macrolides and the development of infantile hypertrophic pyloric stenosis:a systematic review and meta-analysis[J].Eur J Pediatr,2019,178(3):301-314.DOI:10.1007/s00431-018-3287-7.
[9] Meissner PE,Engelmann G,Troeger J,et al.Conservative treatment of infantile hypertrophic pyloric stenosis with intravenous atropine sulfate does not replace pyloromyotomy[J].Pediatr Surg Int,2006,22(12):1021-1024.DOI:10.1007/s00383-006-1751-3.
[10] Nagita A,Yamaguchi J,Amemoto K,et al.Management and ultrasonographic appearance of infantile hypertrophic pyloric stenosis with intravenous atropine sulfate[J].J Pediatr Gastroenterol Nutr,1996,23(2):172-177.DOI:10.1097/00005176-199608000-00013.
[11] Wu SF,Lin HY,Huang FK,et al.Efficacy of medical treatment for infantile hypertrophic pyloric stenosis:a meta-analysis[J].Pediatr Neonatol,2016,57(6):515-521.DOI:10.1016/j.pedneo.2016.02.005.
[12] Garfield K,Sergent SR.Pyloric stenosis [M/OL]//Anon.StatPearls [Internet].Treasure Island:Stat Pearls Publishing,2023:NBK555931.https://pubmed.ncbi.nlm.nih.gov/32310391/.
[13] Kapoor R,Kancherla V,Cao YY,et al.Prevalence and descriptive epidemiology of infantile hypertrophic pyloric stenosis in the United States:a multistate,population-based retrospective study,1999-2010[J].Birth Defects Res,2019,111(3):159-169.DOI:10.1002/bdr2.1439.
[14] Kobayashi J.Nitrite in breast milk:roles in neonatal pathophysiology[J].Pediatr Res,2021,90(1):30-36.DOI:10.1038/s41390-020-01247-y.
[15] Gezer H?,Oguzkurt P,Temiz A,et al.Hypertrophic pyloric stenosis in twins;genetic or environmental factors[J].Clin Genet,2015,87(4):388-391.DOI:10.1111/cge.12399.
[16] 段利琼,任红霞.先天性肥厚性幽门狭窄致病因素及发病机制[J].国际儿科学杂志,2017,44(2):120-123.DOI:10.3760/cma.j.issn.1673-4408.2017.02.012. Duan LQ,Ren HX.Pathogenic factors and mechanisms of congenital hypertrophic pyloric stenosis[J].Int J Pediatr,2017,44(2):120-123.DOI:10.3760/cma.j.issn.1673-4408.2017.02.012.
[17] Tandircioglu UA,Turer OB,Soyer T,et al.Effect of prostaglandin-E1 treatment on pyloric wall thickness in newborns with ductal-dependent critical congenital heart diseases[J].Pediatr Surg Int,2023,39(1):144.DOI:10.1007/s00383-023-05428-8.
[18] Sar?kaya M,?iftci I[DD(-*2/5][HT7.]·[HT8.],Vnlükal N,et al.The effect of botulinum toxin in experimental hypertrophic pyloric stenosis[J].J Laparoendosc Adv Surg Tech A,2021,31(12):1460-1465.DOI:10.1089/lap.2021.0308.
[19] El-Gohary Y,Abdelhafeez A,Paton E,et al.Pyloric stenosis:an enigma more than a century after the first successful treatment[J].Pediatr Surg Int,2018,34(1):21-27.DOI:10.1007/s00383-017-4196-y.
[20] Miura S,Haku E,Hirai T,et al.Ultrasound follow-up of infantile hypertrophic pyloric stenosis (IHPS) during conservative therapy:ultrasound findings as criteria for diagnosis and cure[J].J Med Ultrason (2001),2008,35(2):51-56.DOI:10.1007/s10396-008-0174-2.
[21] 樊剑锋,王达丰,浦晓,等.先天性肥厚性幽门狭窄的治疗策略[J].中华小儿外科杂志,2015,36(11):818-823.DOI:10.3760/cma.j.issn.0253-3006.2015.11.005. Fan JF,Wang DF,Pu X,et al.Therapeutic strategies for congenital hypertrophic pyloric stenosis[J].Chin J Pediatr Surg,2015,36(11):818-823.DOI:10.3760/cma.j.issn.0253-3006.2015.11.005.
[22] Wu TC.A reappraisal of medical treatment of infantile hypertrophic pyloric stenosis[J].Acta Paediatr Taiwan,2004,45(3):129-130.
[23] Singh UK,Kumar R,Prasad R.Oral atropine sulfate for infantile hypertrophic pyloric stenosis[J].Indian Pediatr,2005,42(5):473-476.
[24] Kawahara H,Takama Y,Yoshida H,et al.Medical treatment of infantile hypertrophic pyloric stenosis:should we always slice the "olive"?[J].J Pediatr Surg,2005,40(12):1848-1851.DOI:10.1016/j.jpedsurg.2005.08.025.
[25] Cubas RF,Longshore S,Rodriguez S,et al.Atropine:a cure for persistent post laparoscopic pyloromyotomy emesis?[J].J Neonatal Surg,2017,6(1):2.DOI:10.21699/jns.v6i1.485.
[26] 余东海.阿托品治疗婴儿肥厚性幽门狭窄:也是一种选择?[J].中华小儿外科杂志,2015,36(11):821-823. Yu DH.Atropine dosing for hypertrophic pyloric stenosis in infants:is it also an option?[J].Chin J Pediatr Surg,2015,36(11):821-823.
[27] Lauriti G,Cascini V,Chiesa PL,et al.Atropine treatment for hypertrophic pyloric stenosis:a systematic review and meta-analysis[J].Eur J Pediatr Surg,2018,28(5):393-399.DOI:10.1055/s-0037-1604116.
[28] Ono S,Takenouchi A,Terui K,et al.Risk factors for unsuccessful atropine therapy in hypertrophic pyloric stenosis[J].Pediatr Int,2019,61(11):1151-1154.DOI:10.1111/ped.14009.
[29] Koike Y,Uchida K,Nakazawa M,et al.Predictive factors of negative outcome in initial atropine therapy for infantile hypertrophic pyloric stenosis[J].Pediatr Int,2013,55(5):619-623.DOI:10.1111/ped.12137.
[30] Singh UK,Kumar R,Suman S.Successful management of infantile hypertrophic pyloric stenosis with atropine sulfate[J].Indian Pediatr,2001,38(10):1099-1105.
[31] Kawahara H,Imura K,Nishikawa M,et al.Intravenous atropine treatment in infantile hypertrophic pyloric stenosis[J].Arch Dis Child,2002,87(1):71-74.DOI:10.1136/adc.87.1.71.
[32] Takeuchi M,Yasunaga H,Horiguchi H,et al.Pyloromyotomy versus i.v.atropine therapy for the treatment of infantile pyloric stenosis:nationwide hospital discharge database analysis[J].Pediatr Int,2013,55(4):488-491.DOI:10.1111/ped.12100.
[33] Yamataka A,Tsukada K,Yokoyama-Laws Y,et al.Pyloromyotomy versus atropine sulfate for infantile hypertrophic pyloric stenosis[J].J Pediatr Surg,2000,35(2):338-342.DOI:10.1016/S0022-3468(00)90036-8.
[34] Theobald I,Rohrschneider WK,Meissner PE,et al.[Hypertrophic pyloric stenosis:sonographic monitoring of conservative therapy with intravenous atropine sulfate][J].Ultraschall Med,2000,21(4):170-175.DOI:10.1055/s-2000-6921.
Memo
收稿日期:2023-01-31。
基金项目:无锡市科学技术局项目(N20192040)
通讯作者:樊剑锋,Email:fanjianfeng009@163.com